首页|新辅助化疗联合阴式广泛子宫切除术治疗Ⅱa期局部肿块型宫颈癌的临床疗效

新辅助化疗联合阴式广泛子宫切除术治疗Ⅱa期局部肿块型宫颈癌的临床疗效

扫码查看
目的 探讨新辅助化疗联合阴式广泛子宫切除术对Ⅱa期局部肿块型宫颈癌的治疗效果.方法 根据治疗方式的不同将97例Ⅱa期局部肿块型宫颈癌患者分为观察组(n=47)和对照组(n=50),对照组患者接受阴式广泛子宫切除术治疗,观察组患者接受新辅助化疗联合阴式广泛子宫切除术治疗.评估观察组患者的临床疗效,比较两组患者肿瘤标志物[癌胚抗原(CEA)、鳞状细胞癌抗原(SCC-Ag)、糖类抗原15-3(CA15-3)]水平、T淋巴细胞亚群(CD3+、CD4+、CD8+、CD4+/CD8+)水平、生活质量[世界卫生组织生活质量测定量表简表(WHOQOL-BREF)]及不良反应发生情况.结果 观察组患者的总有效率为78.72%.手术后,两组患者CEA、SCC-Ag、CA15-3水平均低于本组治疗前,观察组患者CEA、SCC-Ag、CA15-3水平均低于对照组,差异均有统计学意义(P<0.05).手术后,观察组患者CD3+、CD4+水平和CD4+/CD8+均高于对照组,CD8+水平低于对照组,差异均有统计学意义(P<0.05).手术后,两组患者生理、心理、环境、社会关系评分均高于本组治疗前,观察组患者生理、心理、环境、社会关系评分均高于对照组,差异均有统计学意义(P<0.05).两组患者恶心呕吐、脱发、骨髓抑制、肝肾功能减退发生率比较,差异均无统计学意义(P>0.05).结论 新辅助化疗联合阴式广泛子宫切除术对Ⅱa期局部肿块型宫颈癌的治疗效果较好,可降低肿瘤标志物水平,改善免疫功能,提高生活质量,且不良反应发生率较低.
Clinical efficacy of neoadjuvant chemotherapy combined with vaginal extensive hysterectomy on stage Ⅱa local mass cervical cancer
Objective To analyze the clinical efficacy of neoadjuvant chemotherapy combined with vaginal extensive hysterectomy on stage Ⅱa local mass cervical cancer.Method A total of 97 patients with stage Ⅱa local mass cervical cancer were selected,according to different treatment methods,they were divided into observation group(n=47)and con-trol group(n=50).The control group received vaginal extensive hysterectomy,while the observation group received neo-adjuvant chemotherapy combined with vaginal extensive hysterectomy.The clinical efficacy of observation group was evaluated,and the tumor marker[carcinoembryonic antigen(CEA),squamous cell carcinoma antigen(SCC-Ag),carbohy-drate antigen 15-3(CA15-3)]levels,T lymphocyte subsets(CD3+,CD4+,CD8+,CD4+/CD8+)levels,quality of life[World Health Organization quality of life assessment instrument brief version(WHOQOL-BREF)],and incidence of adverse re-actions were compared between the two groups.Result The total effective rate of observation group was 78.72%.After surgery,the levels of CEA,SCC-Ag,and CA15-3 in both groups were lower than those before the treatment,the levels of CEA,SCC-Ag,and CA15-3 in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).After surgery,the levels of CD3+,CD4+,and CD4+/CD8+in the observation group were higher than those in the control group,while the level of CD8+was lower than that in the control group,and the differenc-es were statistically significant(P<0.05).After surgery,the physiological,psychological,environmental,and social rela-tionship scores of the two groups were higher than those before the treatment,the physiological,psychological,environ-mental,and social relationship scores of the observation group were higher than those of the control group,and the differ-ences were statistically significant(P<0.05).There were no statistically significant differences in the incidence of nausea,vomiting,hair loss,bone marrow suppression,and liver and kidney dysfunction between the two groups(P>0.05).Conclusion Neoadjuvant chemotherapy combined with vaginal extensive hysterectomy is effective in the treatment of stage Ⅱa local mass cervical cancer,which can reduce tumor marker levels,improve immune function,and improve quali-ty of life,with low incidence of adverse reactions.

cervical cancerneoadjuvant chemotherapyvaginal extensive hysterectomylocal mass typetreatment effect

随艳红、李红霞、李杏丽

展开 >

平顶山市妇幼保健院妇产科,河南 平顶山 467000

宫颈癌 新辅助化疗 阴式广泛子宫切除术 局部肿块型 治疗效果

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(3)